307 related articles for article (PubMed ID: 19855081)
21. The BCL6-associated transcriptional co-repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation.
Jaye DL; Iqbal J; Fujita N; Geigerman CM; Li S; Karanam S; Fu K; Weisenburger DD; Chan WC; Moreno CS; Wade PA
J Pathol; 2007 Sep; 213(1):106-15. PubMed ID: 17573669
[TBL] [Abstract][Full Text] [Related]
22. Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia.
Geng H; Hurtz C; Lenz KB; Chen Z; Baumjohann D; Thompson S; Goloviznina NA; Chen WY; Huan J; LaTocha D; Ballabio E; Xiao G; Lee JW; Deucher A; Qi Z; Park E; Huang C; Nahar R; Kweon SM; Shojaee S; Chan LN; Yu J; Kornblau SM; Bijl JJ; Ye BH; Ansel KM; Paietta E; Melnick A; Hunger SP; Kurre P; Tyner JW; Loh ML; Roeder RG; Druker BJ; Burger JA; Milne TA; Chang BH; Müschen M
Cancer Cell; 2015 Mar; 27(3):409-25. PubMed ID: 25759025
[TBL] [Abstract][Full Text] [Related]
23. Syk mediates BCR- and CD40-signaling integration during B cell activation.
Ying H; Li Z; Yang L; Zhang J
Immunobiology; 2011 May; 216(5):566-70. PubMed ID: 21074890
[TBL] [Abstract][Full Text] [Related]
24. Tonic B-cell receptor signaling in diffuse large B-cell lymphoma.
Havranek O; Xu J; Köhrer S; Wang Z; Becker L; Comer JM; Henderson J; Ma W; Man Chun Ma J; Westin JR; Ghosh D; Shinners N; Sun L; Yi AF; Karri AR; Burger JA; Zal T; Davis RE
Blood; 2017 Aug; 130(8):995-1006. PubMed ID: 28646116
[TBL] [Abstract][Full Text] [Related]
25. Suboptimal B-cell antigen receptor signaling activity in vivo elicits germinal center counterselection mechanisms.
Königsberger S; Weis V; Prodöhl J; Stehling M; Hobeika E; Reth M; Kiefer F
Eur J Immunol; 2015 Feb; 45(2):603-11. PubMed ID: 25382621
[TBL] [Abstract][Full Text] [Related]
26. Activation of the Syk tyrosine kinase is insufficient for downstream signal transduction in B lymphocytes.
Hsueh RC; Hammill AM; Lee JA; Uhr JW; Scheuermann RH
BMC Immunol; 2002 Dec; 3():16. PubMed ID: 12470302
[TBL] [Abstract][Full Text] [Related]
27. Autoinhibition and adapter function of Syk.
Kulathu Y; Grothe G; Reth M
Immunol Rev; 2009 Nov; 232(1):286-99. PubMed ID: 19909371
[TBL] [Abstract][Full Text] [Related]
28. A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.
Hatzi K; Jiang Y; Huang C; Garrett-Bakelman F; Gearhart MD; Giannopoulou EG; Zumbo P; Kirouac K; Bhaskara S; Polo JM; Kormaksson M; MacKerell AD; Xue F; Mason CE; Hiebert SW; Prive GG; Cerchietti L; Bardwell VJ; Elemento O; Melnick A
Cell Rep; 2013 Aug; 4(3):578-88. PubMed ID: 23911289
[TBL] [Abstract][Full Text] [Related]
29. The Syk-binding ubiquitin ligase c-Cbl mediates signaling-dependent B cell receptor ubiquitination and B cell receptor-mediated antigen processing and presentation.
Katkere B; Rosa S; Drake JR
J Biol Chem; 2012 May; 287(20):16636-44. PubMed ID: 22451666
[TBL] [Abstract][Full Text] [Related]
30. PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas.
Franco R; Scognamiglio G; Valentino E; Vitiello M; Luciano A; Palma G; Arra C; La Mantia E; Panico L; Tenneriello V; Pinto A; Frigeri F; Capobianco G; Botti G; Cerchia L; De Chiara A; Fedele M
Oncotarget; 2016 Sep; 7(37):59158-59172. PubMed ID: 27494852
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution of B cell antigen receptor-induced signaling events in a nonlymphoid cell line by expressing the Syk protein-tyrosine kinase.
Richards JD; Gold MR; Hourihane SL; DeFranco AL; Matsuuchi L
J Biol Chem; 1996 Mar; 271(11):6458-66. PubMed ID: 8626447
[TBL] [Abstract][Full Text] [Related]
32. Rapid desensitization of B-cell receptor by a dithiol-reactive protein tyrosine phosphatase inhibitor: uncoupling of membrane IgM from syk inhibits signals leading to Ca2+ mobilization.
Rozsnyay Z; Sarmay G; Gergely J
Immunol Lett; 1995 Jan; 44(2-3):149-56. PubMed ID: 7541023
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of constitutive and BCR-induced Syk activation downregulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia B cells.
Gobessi S; Laurenti L; Longo PG; Carsetti L; Berno V; Sica S; Leone G; Efremov DG
Leukemia; 2009 Apr; 23(4):686-97. PubMed ID: 19092849
[TBL] [Abstract][Full Text] [Related]
34. Cbl-b negatively regulates B cell antigen receptor signaling in mature B cells through ubiquitination of the tyrosine kinase Syk.
Sohn HW; Gu H; Pierce SK
J Exp Med; 2003 Jun; 197(11):1511-24. PubMed ID: 12771181
[TBL] [Abstract][Full Text] [Related]
35. SYK inhibition and response prediction in diffuse large B-cell lymphoma.
Cheng S; Coffey G; Zhang XH; Shaknovich R; Song Z; Lu P; Pandey A; Melnick AM; Sinha U; Wang YL
Blood; 2011 Dec; 118(24):6342-52. PubMed ID: 22025527
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of SYK or BTK augments venetoclax sensitivity in SHP1-negative/BCL-2-positive diffuse large B-cell lymphoma.
Sasi BK; Martines C; Xerxa E; Porro F; Kalkan H; Fazio R; Turkalj S; Bojnik E; Pyrzynska B; Stachura J; Zerrouqi A; Bobrowicz M; Winiarska M; Priebe V; Bertoni F; Mansouri L; Rosenquist R; Efremov DG
Leukemia; 2019 Oct; 33(10):2416-2428. PubMed ID: 30872780
[TBL] [Abstract][Full Text] [Related]
37. BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells.
Ranuncolo SM; Polo JM; Melnick A
Blood Cells Mol Dis; 2008; 41(1):95-9. PubMed ID: 18346918
[TBL] [Abstract][Full Text] [Related]
38. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
[TBL] [Abstract][Full Text] [Related]
39. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
[TBL] [Abstract][Full Text] [Related]
40. AID assists DNMT1 to attenuate BCL6 expression through DNA methylation in diffuse large B-cell lymphoma cell lines.
Jiao J; Lv Z; Zhang P; Wang Y; Yuan M; Yu X; Otieno Odhiambo W; Zheng M; Zhang H; Ma Y; Ji Y
Neoplasia; 2020 Mar; 22(3):142-153. PubMed ID: 32062068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
